BBIO•benzinga•
JP Morgan Maintains Overweight on BridgeBio Pharma, Raises Price Target to $50
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 24, 2025 by benzinga